FDA Approves New Cancer Treatment – OzarksFirst.com
OzarksFirst.com |
FDA Approves New Cancer Treatment
OzarksFirst.com WASHINGTON – The Food and Drug Administration approved a treatment that engineers a patient’s own blood cells to fight the illness. It’s the first type of gene therapy to hit the US market. It has already been used to treat children dying from leukemia … |
Telegraph.co.uk |
US biotech Kite set to be first to launch one-time cancer gene therapy in Britain
Telegraph.co.uk US biotech Kite is expected to be first out of the blocks in Britain to launch a one-time genetic treatment for a type of cancer, in a global market expected to hit $54bn (£41.6bn) in value. The first so-called CAR-T treatment, developed by Swiss giant … |
The CT Mirror |
Kymriah, the First Gene Therapy, Arrives—With a $475000 Price Tag
ConsumerReports.org The Food and Drug Administration’s approval of Kymriah was met with excitement for its potential—as well as concerns about the $475,000 cost of this breakthrough gene therapy treatment for a life-threatening form of childhood cancer. In July, an FDA … Pioneering gene therapy gets green light — and $475000 priceThe CT Mirror Has the Era of Gene Therapy Finally Arrived?Scientific American (blog) First gene therapy that targets leukemia approved in the USKTIC BioWorld Online –CNBC –KTRK-TV all 38 news articles » |
South Bend Tribune |
South Bend man a ‘walking miracle’ after cancer treatment breakthrough
South Bend Tribune If that FDA approval comes — and UCM is preparing for it to come very soon — UCM will have one of the only facilities in the Midwest certified to administer chimeric antigen receptor T-cell infusion, or CAR T-cell, a newer form of immunotherapy. |
South Bend Tribune |
South Bend man benefits from cancer breakthrough
South Bend Tribune If that FDA approval comes — and UCM is preparing for it to come very soon — UCM will have one of the only facilities in the Midwest certified to administer chimeric antigen receptor T-cell infusion, or CAR T-cell, a newer form of immunotherapy. |
The CT Mirror |
Pioneering gene therapy gets green light — and $475000 price
The CT Mirror The country’s first approved gene therapy — approved Wednesday to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment, its manufacturer announced. Switzerland-based Novartis, which makes the innovative therapy … Has the Era of Gene Therapy Finally Arrived? – Scientific American …Scientific American (blog) First gene therapy that targets leukemia approved in the US …kwbe Gene therapy Kymriah: What’s in a name? | BioWorldBioWorld Online CNBC –KTRK-TV –The Pharma Letter (registration) all 36 news articles » |